Key Details
Price
$14.19PE Ratio
54.06Annual ROE
132.50%Beta
0.64Events Calendar
Next earnings date:
Feb 28, 2025Recent quarterly earnings:
Nov 7, 2024Recent annual earnings:
N/ANext ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Market Data
Price
Market cap
Technical
Dividend
Profitability
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Liquidity
Leverage
Risk & Stability
Balance Sheet
Assets
Equity
Liabilities
Debt
Expenses
Cash Flow
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
NEW YORK, NY / ACCESS Newswire / February 5, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of PACS Group, Inc. ("PACS Group" or "the Company") (NYSE:PACS). Investors who purchased PACS Group securities prior to April 11, 2024, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/PACS.
NEW YORK, NY / ACCESS Newswire / February 2, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of PACS Group, Inc. ("PACS Group" or "the Company") (NYSE:PACS). Investors who purchased PACS Group securities prior to April 11, 2024, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/PACS.
Investors can contact the law firm at no cost to learn more about recovering their losses
NEW YORK, Jan. 13, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of PACS Group Inc. (NYSE: PACS) of (i) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) in connection with the Company's April 11, 2024 initial public offering ("IPO"); (ii) securities between April 11, 2024 and November 5, 2024, both dates inclusive (the “Class Period”); and/or (iii) common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company's September 2024 secondary public offering (“SPO”), of the important January 13, 2025 lead plaintiff deadline.
NEW YORK, NY / ACCESSWIRE / January 13, 2025 / If you suffered a loss on your PACS Group, Inc. (NYSE:PACS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/pacs-group-inc-lawsuit-submission-form?prid=122567&wire=1 or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / January 13, 2025 / If you suffered a loss on your PACS Group, Inc. (NYSE:PACS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/pacs-group-inc-lawsuit-submission-form?prid=122533&wire=1 or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / January 13, 2025 / If you suffered a loss on your PACS Group, Inc. (NYSE:PACS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/pacs-group-inc-lawsuit-submission-form?prid=122523&wire=1 or contact Joseph E. Levi, Esq.
RADNOR, PA / ACCESSWIRE / January 13, 2025 / The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against PACS Group, Inc. ("PACS") (NYSE:PACS). The lawsuit is brought on behalf of investors who purchased or otherwise acquired PACS: 1) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement") issued in connection with PACS' April 11, 2024 initial public offering (the "IPO"); and/or 2) securities between April 11, 2024 and November 5, 2024 inclusive (the "Class Period").
NEW YORK, NY / ACCESSWIRE / January 13, 2025 / If you suffered a loss on your PACS Group, Inc. (NYSE:PACS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/pacs-group-inc-lawsuit-submission-form?prid=122460&wire=1 or contact Joseph E. Levi, Esq.
NEW YORK CITY, NY / ACCESSWIRE / January 13, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against PACS Group, Inc. ("PACS Group" or "the Company") (NYSE:PACS) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired PACS Group: (a) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement") issued in connection with the Company's April 11, 2024 initial public offering ("IPO" or the "Offering"); and/or (b) securities between April 11, 2024 and November 5, 2024, both dates inclusive ("the Class Period"); and/or (c) common stock pursuant, or traceable, or both, to the SPO Materials issued in connection with PACS' September 2024 secondary public offering (the "SPO").
FAQ
- What is the ticker symbol for PACS?
- Does PACS pay dividends?
- What sector is PACS in?
- What industry is PACS in?
- What country is PACS based in?
- When did PACS go public?
- Is PACS in the S&P 500?
- Is PACS in the NASDAQ 100?
- Is PACS in the Dow Jones?
- When was PACS's last earnings report?
- When does PACS report earnings?
- Should I buy PACS stock now?